Nicholas Morrow

Linebacker

Age: 29
Free Agency: 2025 (UFA)
Accrued Seasons: 7
  • 2024 Salary Cap Charge: $1,500,000 (0.59% of cap)
  • 2024 Cash Payout: $1,500,000 (0.62% of spending)
  • 2024 Cash to Cap Ratio: 1.00
  • Contract Value: $1,500,000 ($1,500,000 APY)
  • Fully Guaranteed Money: $750,000
  • Contract Ranking: 69/216 at LB

Current Contract

(UFA, signed 2024)
(📝: indicates contract trigger occuring during that year)
YearAgeBase SalaryProrated Signing BonusWorkout BonusGuaranteed SalaryCap
Number
Cap %
Dead Money & Cap Savings
202429$1,210,000$250,000$40,000$500,000$1,500,0000.6%
Total$1,210,000$250,000$40,000$500,000$1,500,000

Contract Notes

Nicholas Morrow signed a one year, $1.5 million contract with the Bills. $750,000 is guaranteed.

 

Cash Flows

- fully earned money
- unearned or partially earned money
$1.5M
2024
Cash Due$1,500,000
Running Cash$1,500,000
Career Earnings: $14,776,500
Career APY: $2,110,929
Potential Earnings: $16,001,500
Total Guarantees: $7,807,500
Largest Cash Payment: $4,500,000 (2021)
Largest Cap Number: $4,500,000 (2021)

Contract History

TeamContract TypeStatusYear SignedYrsTotalAPYGuaranteesAmount Earned% EarnedEffective APY
RaidersUDFAExpired20173$1,672,500$557,500$7,500$1,672,500100.0%$557,500
RaidersRFAExpired20201$3,259,000$3,259,000$0$3,259,000100.0%$3,259,000
RaidersUFAExpired20211$4,500,000$4,500,000$4,500,000$4,500,000100.0%$4,500,000
BearsUFAExpired20221$3,000,000$3,000,000$2,500,000$4,000,000133.3%$4,000,000
EaglesUFATerminated20231$1,155,000$1,155,000$0$00.0%$0
EaglesPracticeRenegotiated20231$370,800$370,800$0$00.0%$0
EaglesSFAExpired20231$1,130,000$1,130,000$50,000$1,070,00094.7%$1,070,000
BillsUFAActive20241$1,500,000$1,500,000$750,000$250,00016.7%$0
Earnings By Team
TeamYrsSalaryAPYPaid on Cap% Paid on CapPaid as Dead Money% Paid as Dead Money
Raiders5$9,431,500$1,886,300$9,431,5000.0%$00.0%
Bears1$4,000,000$4,000,000$3,000,0000.0%$00.0%
Eagles1$1,095,000$1,095,000$1,012,7780.0%$45,6000.0%
Bills0$250,000$0$00.0%$00.0%

Season History

YearTeamBase SalaryProrated BonusPer Game Roster BonusWorkout BonusOther BonusGuaranteed SalaryCap
Number
Cap %Cash Paid
2017Raiders$465,000$2,500$0$0$0$0$467,5000.3%$472,500
2018Raiders$555,000$2,500$0$0$0$0$557,5000.3%$555,000
2019Raiders$645,000$2,500$0$0$0$0$647,5000.3%$645,000
2020Raiders$3,259,000$0$0$0$0$0$3,259,0001.5%$3,259,000
2021Raiders$2,250,000$2,250,000$0$0$0$2,250,000$4,500,0002.4%$4,500,000
2022Bears$1,250,000$1,250,000$500,000$0$0$1,250,000$3,000,0001.4%$4,000,000
2023Eagles$1,080,000$50,000$0$0$75,000$0$1,012,7780.4%$1,070,000
2024Bills$1,210,000$250,000$0$40,000$0$500,000$1,500,0000.6%$1,500,000
Total$10,714,000$3,807,500$500,000$40,000$75,000$4,000,000$14,944,278$16,001,500
Dead Money History
TeamYearCap ChargeCash Paid
Eagles2023$25,000$25,000
Eagles2023$20,600$0
Total$45,600$25,000

Statistics

YearGames PlayedGames InactiveSnapsTacklesNegative PlaysInterceptionsFumblesTD
InjuredHealthyDefenseSpecialSoloAssistSacksYardsTFLQB HitsPass Def.INTYardsForcedRec.Yards
2017160053.3%41.8%12500111000000
2018160040.3%63.7%301314533001000
2019160070.2%47.4%5320002441110000
2020141066.4%24.9%6016329869101100
2022170099.8%20.9%8333001102100000
2023151071.8%26.1%65283201255001100

Valuation Diamond

The diamond is a scatterplot graph that visualizes the relation of the player's APY (in green) and performance (in blue, as measured by OTC's Valuations) to the rest of the league at his position. To understand how to read the diamond, read this explainer.

OTC ValuationAPY
Regular$6,300,000$1,500,000
Injury Adjusted$6,899,467$1,406,250
test
OTC Valuation $3.1M $6.1M $9.2M $12.2M $15.3M APY $3.3M $6.7M $10M $13.3M $16.7M $4,874,000 $3,000,000

Weekly Valuation Trends

The chart below illustrates the trend of the player's weekly OTC Valuations (in blue) from the most recent season, using APY (in green) and, if applicable, cash that is due to the player in the next season (in red) as benchmarks. Weeks not plotted indicate that the player was inactive or on a bye.

To see interactive and more in-depth use of OTC Valuation data, subscribe to OTC Premium.